OX1 RECEPTOR ANTAGONISTS
Application
US20260085056A1
Kind: A1
Mar 26, 2026
Assignee
NXERA PHARMA UK LIMITED
Inventors
Giles Albert BROWN, Miles Stuart CONGREVE, John Andrew CHRISTOPHER, Nigel Alan SWAIN, Sarah Joanne BUCKNELL, Anne Mary STEPHENSON, Benjamin Gerald TEHAN, Mark MILLS, Anil PATEL
Abstract
The disclosures herein relate to novel compounds of formula (I); and salts thereof, wherein W; X; Y; Z; R1; R2; R3 and R4 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of neurological or psychiatric disorders associated with orexin receptors.
CPC Classifications
C07D 401/04
C07D 239/26
C07D 241/12
C07D 401/12
Filing Date
2025-05-09
Application No.
19203332